| Bioactivity | Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2. |
| In Vivo | Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, in particular atrial and ventricular arrhythmias[1]. |
| Name | Arrhythmias-Targeting Compound 1 |
| CAS | 335619-12-0 |
| Formula | C22H32N4O2 |
| Molar Mass | 384.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Björe, Annika, et al. NEW OXABISPIDINE COMPOUNDS USEFUL IN THE TREATMENT OF CARDIAC ARRHYTHMIAS. WO 2001028992 A2. |
Arrhythmias-Targeting Compound 1
CAS: 335619-12-0 F: C22H32N4O2 W: 384.52
Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.